Group 1 - The core point of the news is that Shenzhou Cell's stock price increased by 5.01% to 55.09 CNY per share, with a trading volume of 102 million CNY and a turnover rate of 0.42%, resulting in a total market capitalization of 24.534 billion CNY [1] - Shenzhou Cell, established on April 23, 2007, and listed on June 22, 2020, is based in Beijing and focuses on the research and industrialization of biopharmaceutical products for various diseases, including malignant tumors, autoimmune diseases, infectious diseases, and genetic disorders [1] - The company's main business revenue is entirely derived from product sales, accounting for 100% of its income [1] Group 2 - From the perspective of fund holdings, Shenzhou Cell is the top holding of the Galaxy Quantitative Optimal Mixed A Fund (004250), which held 6,529 shares in the second quarter, representing 2.13% of the fund's net value [2] - The Galaxy Quantitative Optimal Mixed A Fund has a current scale of 17.7364 million CNY and has achieved a year-to-date return of 24.01%, ranking 3,463 out of 8,161 in its category [2] - The fund manager, Luo Bo, has a tenure of 15 years and 296 days, with the fund's total asset size at 2.75 billion CNY, achieving a best return of 165.8% during his tenure [2]